---
title: "Expressions of Interest for Provision of Parenteral Methotrexate Services"
ocid: "ocds-h6vhtk-02d11e"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02d11e"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02d11e.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02d11e.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS DERBY AND DERBYSHIRE CLINICAL COMMISSIONING GROUP"
published: "2021-08-05"
---

# Expressions of Interest for Provision of Parenteral Methotrexate Services

Buyer: NHS DERBY AND DERBYSHIRE CLINICAL COMMISSIONING GROUP  
Current stage: Planning  
OCID: ocds-h6vhtk-02d11e

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02d11e)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02d11e.json)

## Summary

The NHS Derby and Derbyshire Clinical Commissioning Group is planning a procurement for the provision of parenteral methotrexate services, with the title "Expressions of Interest for Provision of Parenteral Methotrexate Services." This opportunity falls under the health services category and is located in North Derbyshire. The procurement is currently in the planning stage, with an anticipated contract start date of 1st April 2022. The total anticipated value of the 12-month contract is £221,263, which includes both service and drug costs. Interested providers are required to submit their expressions of interest via the EU Supply Portal by 6th August 2021.

This tender presents an opportunity for businesses specialising in health services, particularly those capable of dispensing and delivering parenteral medications and managing clinical cytotoxic waste. Companies that can demonstrate experience in complying with NHS regulations and providing consistent, timely delivery of medical supplies would be particularly well-suited for this contract. Additionally, businesses that provide clinical supports, such as patient education regarding the medications and associated waste management, should consider this as a potential avenue for growth and engagement with NHS entities.

## Notice

NHS Arden & Greater East Midlands Commissioning Support Unit (NHS Arden & GEM CSU) on behalf of NHS Derby and Derbyshire Clinical Commissioning Group are inviting Expressions of Interest from suitably qualified providers capable of dispensing and delivering parenteral methotrexate to patients and collecting and disposing of the associated clinical cytotoxic waste in line with appropriate legislation. The requirement will be for a 12-month contract (only) commencing 01st April 2022. The anticipated total value of the 12-month contract is PS221,263. This value is based on the service cost (currently approximately 18% of the total contract value) and the drug cost (currently approximately 82% of the total current value). The service cost is paid by the CCG, the drug cost will be reimbursed via NHS BSA. This value is based on historical data and is not guaranteed. The contract may be terminated by the Commissioner at any time within the specified duration of the contract. The Commissioner will give 12 weeks' notice of cancellation to the provider in the event of this. The services will include dispensing and delivery of licensed parenteral methotrexate on an 8 weekly basis to patients within the North Derbyshire Area, provision of clinical cytotoxic waste bins and clinical cytotoxic waste collection and disposal services.. The aims of the Parenteral Methotrexate service are to: * Request prescriptions from patients GP practice in a safe, timely way to ensure patients receive licensed parenteral methotrexate at appropriate intervals. * Ensure prescriptions are in line with clinical information from the hospital to prevent errors. * Delivery of licensed parenteral methotrexate to patients on an 8-weekly basis with contact to the patient prior to delivery to minimise stockpiling and wastage. * Issue methotrexate as per the brand on the prescription - the preferred product is Metoject but other brands may be prescribed on an exceptional basis. * Provide clinical support to patients and clinicians should the brand of parenteral methotrexate change. * Provision of clinical cytotoxic waste bins for safe disposal of clinical waste. * Collection of filled clinical cytotoxic waste bins and appropriate disposal of these in line with legislation. Please note the following patients are excluded from this service: * Those receiving parenteral methotrexate for non-rheumatology indications * Those under the age of 18 * Those receiving unlicensed parenteral methotrexate * Those who are not stable on their parenteral methotrexate dose A service specification providing full details of the service is included within the attachments area of the project on EU-Supply (access link provided below). The aim of this Expression of Interest is to: 1. Allow the market visibility of the proposed opportunity; 2. To inform the CCG's decision making process for the future commissioning of the 8 -weekly delivery of Parenteral Methotrexate to patients homes and provision of cytotoxic waste bins, and collection and destruction of cytotoxic waste; 3. To help refine the future commissioning and procurement approach and; 4. To gauge the level of interest from the market of capable providers with capacity to deliver maintain and strengthen services across North Derbyshire as illustrated above. If you wish to express an interest please register on the EU Supply Portal. The EU supply link is https://uk.eu-supply.com/login.asp?B=UK ref ID no. 45546 Once registered please complete the questions which asks providers to give details about your organisation's name and postal address, email address, contact name and number.

### Lot Information

Lot 1

NHS Arden & Greater East Midlands Commissioning Support Unit (NHS Arden & GEM CSU) on behalf of NHS Derby and Derbyshire Clinical Commissioning Group are inviting Expressions of Interest from suitably qualified providers capable of dispensing and delivering parenteral methotrexate to patients and collecting and disposing of the associated clinical cytotoxic waste in line with appropriate legislation. The requirement will be for a 12-month contract (only) commencing 01st April 2022. The anticipated total value of the 12-month contract is PS221,263. This value is based on the service cost (currently approximately 18% of the total contract value) and the drug cost (currently approximately 82% of the total current value). The service cost is paid by the CCG, the drug cost will be reimbursed via NHS BSA. This value is based on historical data and is not guaranteed. The contract may be terminated by the Commissioner at any time within the specified duration of the contract. The Commissioner will give 12 weeks' notice of cancellation to the provider in the event of this. The services will include dispensing and delivery of licensed parenteral methotrexate on an 8 weekly basis to patients within the North Derbyshire Area, provision of clinical cytotoxic waste bins and clinical cytotoxic waste collection and disposal services.. The aims of the Parenteral Methotrexate service are to: * Request prescriptions from patients GP practice in a safe, timely way to ensure patients receive licensed parenteral methotrexate at appropriate intervals. * Ensure prescriptions are in line with clinical information from the hospital to prevent errors. * Delivery of licensed parenteral methotrexate to patients on an 8-weekly basis with contact to the patient prior to delivery to minimise stockpiling and wastage. * Issue methotrexate as per the brand on the prescription - the preferred product is Metoject but other brands may be prescribed on an exceptional basis. * Provide clinical support to patients and clinicians should the brand of parenteral methotrexate change. * Provision of clinical cytotoxic waste bins for safe disposal of clinical waste. * Collection of filled clinical cytotoxic waste bins and appropriate disposal of these in line with legislation. Please note the following patients are excluded from this service: * Those receiving parenteral methotrexate for non-rheumatology indications * Those under the age of 18 * Those receiving unlicensed parenteral methotrexate * Those who are not stable on their parenteral methotrexate dose A service specification providing full details of the service is included within the attachments area of the project on EU-Supply (access link provided below). The aim of this Expression of Interest is to: 1. Allow the market visibility of the proposed opportunity; 2. To inform the CCG's decision making process for the future commissioning of the 8 -weekly delivery of Parenteral Methotrexate to patients homes and provision of cytotoxic waste bins, and collection and destruction of cytotoxic waste; 3. To help refine the future commissioning and procurement approach and; 4. To gauge the level of interest from the market of capable providers with capacity to deliver maintain and strengthen services across North Derbyshire as illustrated above. If you wish to express an interest please register on the EU Supply Portal. The EU supply link is https://uk.eu-supply.com/login.asp?B=UK ref ID no. 45546 Once registered please complete the questions which asks providers to give details about your organisation's name and postal address, email address, contact name and number.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/018864-2021 |
| Notice type | Planning Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 5 Aug 2021 |
| Submission deadline | Not specified |
| Future notice date | 5 Aug 2021 |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £221,263 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS DERBY AND DERBYSHIRE CLINICAL COMMISSIONING GROUP |
| Locality | DERBY |
| Post town | Derby |
| Postcode | DE1 3QT |
| Country | England |
| ITL 1 | TLF East Midlands (England) |
| ITL 2 | TLF1 Derbyshire and Nottinghamshire |
| ITL 3 | TLF11 Derby |
| Local authority | Derby |
| Electoral ward | Darley |
| Westminster constituency | Derby North |
| Delivery location | TLF1 Derbyshire and Nottinghamshire |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85100000 - Health services

## Release History

- 5 Aug 2021 at 10:31 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/018864-2021

## Notice URLs

- https://uk.eu-supply.com
- https://uk.eu-supply.com/login.asp?B=UK
- https://www.ardengemcsu.nhs.uk
- https://www.derbyandderbyshireccg.nhs.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02d11e. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02d11e.json.